Cargando…

Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models

In this study we undertook a novel combination therapy using rAd-p53 in situ gene therapy and immunotherapy with immune checkpoint inhibitor (ICI) anti-PD-1 antibody for urogenital cancers. Three mouse syngeneic tumor cell lines, TRAMP-C2 (prostate cancer derived from C57BL/6 mice), MBT-2 (bladder c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kunimura, Naoto, Kitagawa, Koichi, Sako, Ryota, Narikiyo, Keita, Tominaga, Shoko, Bautista, Diosdado S., Xu, Wei, Fujisawa, Masato, Shirakawa, Toshiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562933/ https://www.ncbi.nlm.nih.gov/pubmed/33060772 http://dx.doi.org/10.1038/s41598-020-74660-2

Ejemplares similares

A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer
por: A, Ruhan, et al.
Publicado: (2023)

An oral cancer vaccine using a Bifidobacterium vector suppresses tumor growth in a syngeneic mouse bladder cancer model
por: Kitagawa, Koichi, et al.
Publicado: (2021)

An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model
por: Ueki, Hideto, et al.
Publicado: (2023)

Prevalence of Quinolone Resistance of Extended-Spectrum β-Lactamase-Producing Escherichia coli with ST131-fimH30 in a City Hospital in Hyogo, Japan
por: Teramae, Masazumi, et al.
Publicado: (2019)

rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1
por: Montefiori, DC, et al.
Publicado: (2012)

Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma
por: Rigo, Valentina, et al.
Publicado: (2017)

Rad51 paralogs Rad55-Rad57 balance the anti-recombinase Srs2 in Rad51 filament formation
por: Liu, Jie, et al.
Publicado: (2011)

Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Anti-tumor effect of aquaporin 3 monoclonal antibody on syngeneic mouse tumor model
por: Tanaka, Manami, et al.
Publicado: (2022)

Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine
por: Shirakawa, Toshiro, et al.
Publicado: (2017)

Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: case report
por: Naghashzadeh, Farah, et al.
Publicado: (2022)

Further Observations on the Effect of C. parvum and Anti-Tumour Globulin on Syngeneically Transplanted Mouse Tumours
por: Woodruff, M. F. A., et al.
Publicado: (1972)

Enhancement of anti-tumour immunity in syngeneic mice after MHC class II gene transfection.
por: Mongini, C., et al.
Publicado: (1996)

Clinical manifestation of norovirus infection in children aged less than five years old admitted with acute diarrhea in Surabaya, Indonesia: a cross-sectional study
por: Fardah Athiyyah, Alpha, et al.
Publicado: (2020)

Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4
por: Wang, Zhiyong, et al.
Publicado: (2019)

Sistema urogenital /
por: García Monroy, Leopoldo
Publicado: (1993)

Sistema urogenital
por: García Monroy, Leopoldo
Publicado: (1984)

Urogenital Tuberculosis
por: Band, David
Publicado: (1942)

IL-2 and Anti-TGF-β Promote NK Cell Reconstitution and Anti-tumor Effects after Syngeneic Hematopoietic Stem Cell Transplantation
por: Alvarez, Maite, et al.
Publicado: (2020)

Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
por: Garofalo, Mariangela, et al.
Publicado: (2021)

Advances in urinary protein biomarkers for urogenital and non-urogenital pathologies
por: Pedroza-Díaz, Johanna, et al.
Publicado: (2015)

The anti-tumoral effects of the oxygen carrier YQ23 in a triple-negative breast cancer syngeneic model
por: Chow, Elysian, et al.
Publicado: (2021)

Comparison of cisplatin-induced anti-tumor response in CT26 syngeneic tumors of three BALB/c substrains
por: Gong, Jeong Eun, et al.
Publicado: (2021)

Reverse Translating Molecular Determinants of Anti–Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models
por: Georgiev, Peter, et al.
Publicado: (2022)

Improving the predictive power of xenograft and syngeneic anti-tumour studies using mice humanised for pathways of drug metabolism
por: Henderson, Colin J., et al.
Publicado: (2023)

Rad52 Sumoylation Prevents the Toxicity of Unproductive Rad51 Filaments Independently of the Anti-Recombinase Srs2
por: Esta, Aline, et al.
Publicado: (2013)

Chemotherapy of Urogenital Tumors
por: Pointon, R. S.
Publicado: (1976)

Urogenital tumours in childhood
por: Swinson, S., et al.
Publicado: (2011)

Malakoplakia of the Urogenital Tract
por: Dong, Huan, et al.
Publicado: (2014)

Deroubaix on Urogenital Fistulæ
Publicado: (1871)

Urogenital and Reproductive Emergencies
por: Plunkett, Signe J.
Publicado: (2000)

Anti-CD45 Radioimmunotherapy with (90)Y but Not (177)Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model
por: Orozco, Johnnie J., et al.
Publicado: (2014)

Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment
por: Jin, Ying, et al.
Publicado: (2022)

Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
por: Dong, Xinyue, et al.
Publicado: (2023)

IMMU-01. EVALUATING THE IMPACT OF CAR DESIGN ON THE TUMOR IMMUNE MICROENVIRONMENT AND ANTI-TUMOR RESPONSE IN SYNGENEIC GLIOMA MODELS
por: Haydar, Dalia, et al.
Publicado: (2023)

Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein
por: Pouriayevali, Mohammad Hassan, et al.
Publicado: (2022)

Anti-RANKL Inhibits Thymic Function and Causes DRONJ in Mice
por: Nakamura, Yusuke, et al.
Publicado: (2022)

The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model
por: Dare, Anna J., et al.
Publicado: (2015)

Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response
por: Sato, Yosuke, et al.
Publicado: (2021)

Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)
por: Crank, Michelle C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2p9cfr0a91rpdd3h0j8q14902c